Neuland Laboratories · NSE: NEULANDLAB · BSE: 524558
Q3 FY20 results · Oct–Dec 2019
Neuland Laboratories reported revenue from operations of ₹203.84 crore and net profit of ₹11.11 crore for Q3 FY20 (Oct–Dec 2019), on a consolidated basis.
| Item | Q3 FY20 | Q3 FY19 | YoY | Q2 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 203.84 | — | — | 186.22 | +9.5% |
| Other income | 1.02 | — | — | 0.57 | +79.5% |
| Total income | 204.87 | — | — | 186.79 | +9.7% |
| Profit before tax | 15.67 | — | — | 12.45 | +25.8% |
| Net profit for the period | 11.11 | — | — | 8.69 | +27.9% |
| EPS, basic (₹) | 8.66 | — | — | 6.77 | +27.9% |
| Net margin (%) | 5.5 | — | 4.7 |
| Item | Q3 FY20 | Q3 FY19 | YoY | Q2 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 203.62 | 171.47 | +18.7% | 186.21 | +9.3% |
| Other income | 1.02 | 0.41 | +152.3% | 0.57 | +79.5% |
| Total income | 204.64 | 171.87 | +19.1% | 186.78 | +9.6% |
| Profit before tax | 15.57 | 5.90 | +164.2% | 12.33 | +26.3% |
| Net profit for the period | 11.04 | 4.60 | +140.1% | 8.57 | +28.9% |
| EPS, basic (₹) | 8.61 | 3.59 | +139.8% | 6.68 | +28.9% |
| Net margin (%) | 5.4 | 2.7 | 4.6 |
Consolidated
- Filed with BSE
- 12 Feb 2020, 14:14 IST
- Board meeting
- 11 Feb 2020
- Period
- 01 Oct 2019 to 31 Dec 2019
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 12 Feb 2020, 14:14 IST
- Board meeting
- 11 Feb 2020
- Period
- 01 Oct 2019 to 31 Dec 2019
- Review status
- Unaudited
- Source
- XBRL filing on BSE